Brandy Scott
Medical · Dalton, GANPI 1649338849
Payments from drug & device makers
Across 186 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$860
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$339
- AstraZeneca$248
- Amgen$247
- Novo Nordisk$244
- Lilly USA, LLC$235
- plus $843 from 14 others
What the payments were for
- Food & beverage$3,016100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $860 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $339 |
| AstraZeneca | 15 | $248 |
| Amgen | 18 | $247 |
| Novo Nordisk | 12 | $244 |
| Lilly USA, LLC | 13 | $235 |
| Amneal Pharmaceuticals LLC | 10 | $135 |
| GSK | 7 | $133 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Exact Sciences | 4 | $73 |
| Vanda Pharmaceuticals Inc. | 4 | $70 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Boehringer Ingelheim | 3 | $45 |
| Inspire Medical Systems, Inc. | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $32 |
| Medtronic | 1 | $17 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Otezla$120
How this compares
$3,016 in reported general payments places this provider in the 75th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 106 | $122,074 |
| JardianceEmpagliflozin | 103 | $105,489 |
| EliquisApixaban | 29 | $31,202 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 43 | $28,537 |
| MounjaroTirzepatide | 24 | $25,566 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $25,322 |
| VraylarCariprazine Hcl | 18 | $24,962 |
| FarxigaDapagliflozin Propanediol | 22 | $21,533 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 26 | $14,721 |
| RybelsusSemaglutide | 14 | $12,845 |
| Tresiba Flextouch U-100Insulin Degludec | 21 | $10,894 |
| Varenicline Tartrate | 13 | $3,810 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 108 | $3,218 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 38 | $3,073 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $3,010 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $244 | $134,918120 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $45 | $120,210129 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $248 | $50,07065 claims |
| PfizerEliquis | $13 | $31,20229 claims |
| Lilly USA, LLCMounjaro | $235 | $25,56624 claims |
| GSKTrelegy Ellipta | $133 | $25,32227 claims |
| AbbVieVraylar | $860 | $24,96218 claims |
| Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium | $135 | $2,839126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 950 medical providers in Georgia.
Other medical in Dalton
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Audrey GibsonGainesville$302K
- Lisa WeissCanton$283K
- Laura BushFayetteville$146K
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
- Felicia HoffmanRoswell$114K
- Sally BrumbillLithia Springs$110K
- Danna Dennis-CalderAtlanta$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.